diazepam has been researched along with devazepide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, PS; Bock, MG; Chang, RS; DiPardo, RM; Evans, BE; Freidinger, RM; Lundell, GF; Rittle, KE; Veber, DF; Whitter, WL | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Lin, JH; Lin, TH | 1 |
| Hodgson, OJ; Pullen, RG | 1 |
| Bonnafous, C; Bueno, L; Martinez, J | 1 |
| Bickerdike, MJ; Dourish, CT; Fletcher, A; Marsden, CA | 1 |
| Ballaz, S; Barber, A; Del Río, J; Fortuño, A; García-López, MT; Gómez-Monterrey, I; González-Muñiz, R; Herranz, R; Martin-Martínez, M | 1 |
| Costall, B; Naylor, RJ | 1 |
| Harper, EA; Morton, MF; Shankley, NP; Tavares, IA | 1 |
11 other study(ies) available for diazepam and devazepide
| Article | Year |
|---|---|
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.
Topics: Administration, Oral; Animals; Benzodiazepines; Chemical Phenomena; Chemistry; Cholecystokinin; Drug Design; Mice; Receptors, Cholecystokinin; Receptors, GABA-A; Structure-Activity Relationship | 1988 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Blood-Brain Barrier; Brain; Devazepide; Diabetes Mellitus, Experimental; Diazepam; Kidney Diseases; Liver Diseases; Male; Phenylurea Compounds; Protein Binding; Rats; Rats, Inbred Strains; Serum Albumin | 1990 |
Penetration of diazepam and the non-peptide CCK antagonist, L-364,718, into rat brain.
Topics: Animals; Benzodiazepinones; Brain; Cholecystokinin; Devazepide; Diazepam; Male; Rats; Rats, Inbred Strains | 1987 |
Gastrointestinal effects of diazepam-withdrawal are linked to activation of central cholecystokinin-ergic pathways in rats.
Topics: Animals; Benzodiazepinones; Brain; Cholecystokinin; Devazepide; Diazepam; Flumazenil; Gastrointestinal Motility; Gastrointestinal Transit; Male; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Substance Withdrawal Syndrome | 1994 |
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Devazepide; Diazepam; Indoles; Male; Maze Learning; Meglumine; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Rats; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors; Zimeldine | 1994 |
Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
Topics: Amylases; Animals; Anorexia; Anti-Anxiety Agents; Benzodiazepinones; Carbamates; Cholecystokinin; Devazepide; Diazepam; Disease Models, Animal; Fenfluramine; Guinea Pigs; Hormone Antagonists; Locomotion; Male; Mice; Phenylurea Compounds; Pyrimidinones; Rats; Rats, Wistar; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors | 1997 |
The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Topics: Animals; Avoidance Learning; Behavior, Animal; Benzodiazepinones; Darkness; Devazepide; Diazepam; Drug Antagonism; Fenclonine; Indoles; Light; Losartan; Male; Meglumine; Mice; Organophosphorus Compounds; Proline; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Ritanserin; Serotonin Antagonists; Sulfonamides | 1997 |
Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle.
Topics: Aspartic Acid; Binding Sites; Binding, Competitive; Colon; Devazepide; Diazepam; Gallbladder; Humans; Indoleacetic Acids; Kinetics; Membranes; Models, Biological; Muscle, Smooth; Naphthalenesulfonates; Organ Culture Techniques; Organ Specificity; Protease Inhibitors; Radioligand Assay; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Thiazoles; Time Factors | 2002 |